Absorbed dose kernel and selfâshielding calculations for a novel radiopaque glass microsphere for transarterial radioembolization
Sign Up to like & getrecommendations! Published in 2018 at "Medical Physics"
DOI: 10.1002/mp.12717
Abstract: PURPOSE Radiopaque microspheres may provide intraprocedural and postprocedural feedback during transarterial radioembolization (TARE). Furthermore, the potential to use higher resolution x-ray imaging techniques as opposed to nuclear medicine imaging suggests that significant improvements in the… read more here.
Keywords: glass; transarterial radioembolization; time; self shielding ... See more keywords
Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a non-rigid image registration for voxelwise calculation.
Sign Up to like & getrecommendations! Published in 2022 at "Medical physics"
DOI: 10.1002/mp.16014
Abstract: BACKGROUND Transarterial radioembolization This article is protected by copyright. All rights reserved. read more here.
Keywords: improving mri; based dosimetry; dosimetry holmium; transarterial radioembolization ... See more keywords
18F-FDG PET/CT predicts survival after 90Y transarterial radioembolization in unresectable hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-017-3653-0
Abstract: PurposeTo compare the value of pretreatment functional and morphological imaging parameters for predicting survival in patients undergoing transarterial radioembolization using yttrium-90 (90Y-TARE) for unresectable hepatocellular carcinoma (uHCC).MethodsWe analysed data from 48 patients in our prospective… read more here.
Keywords: 90y tare; transarterial radioembolization; fdg pet; unresectable hepatocellular ... See more keywords
Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium
Sign Up to like & getrecommendations! Published in 2020 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-020-02605-3
Abstract: Hepatocellular carcinoma (HCC) has the tendency to invade the portal and/or hepatic venous system. The invasion of the right atrium is uncommonly observed and constitutes a treatment challenge. We report the case of a patient… read more here.
Keywords: hepatocellular carcinoma; invading right; right atrium; treatment ... See more keywords
Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-021-02745-z
Abstract: Transarterial radioembolization (TARE) with yttrium-90 (Y90) is a promising alternative strategy to treat liver tumors and liver metastasis from colorectal cancer (CRC), as it selectively delivers radioactive isotopes to the tumor via the hepatic artery,… read more here.
Keywords: tare; transarterial radioembolization; ytrrium transarterial; gastrointestinal malignancies ... See more keywords
Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers
Sign Up to like & getrecommendations! Published in 2021 at "Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s13139-021-00709-3
Abstract: Liver tumors, both primary and secondary to metastatic disease, remain a major challenge, with an increasing incidence. In this context, taking advantage of the dual blood supply of the liver, and the fact that liver… read more here.
Keywords: radioembolization agents; radionuclide agents; transarterial radioembolization; radioembolization ... See more keywords
Transarterial Chemoembolization vs Yttrium-90 Transarterial Radioembolization.
Sign Up to like & getrecommendations! Published in 2017 at "Gastroenterology"
DOI: 10.1053/j.gastro.2017.01.062
Abstract: 2 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105… read more here.
Keywords: y90; tace; trial; transarterial radioembolization ... See more keywords
Transarterial radioembolization with Yttrium-90: current status and future prospects
Sign Up to like & getrecommendations! Published in 2020 at "Gastroenterology Report"
DOI: 10.1093/gastro/goz074
Abstract: In recent years, transarterial radioembolization (TARE) with Yttrium-90 (Y90) has emerged as a technique for treating malignant neoplasms in the liver. Compared with other locoregional therapies, such as transarterial chemoembolization (TACE), patients who underwent TARE… read more here.
Keywords: tare; treatment; transarterial radioembolization; group ... See more keywords
Improved survival following transarterial radioembolization of infiltrative-appearance hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e15591
Abstract: e15591 Background: Infiltrative-appearance hepatocellular carcinoma (IHCC), also known as diffuse HCC, presents a distinct challenge to clinicians as evidence-based treatment guidelines have yet to be established. While transarterial radioembolization (TARE) has shown efficacy in HCC,… read more here.
Keywords: hepatocellular carcinoma; transarterial radioembolization; radioembolization; appearance hepatocellular ... See more keywords
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer
Sign Up to like & getrecommendations! Published in 2022 at "European Thyroid Journal"
DOI: 10.1530/etj-22-0130
Abstract: Objectives Liver metastases occur in 45% of patients with advanced metastatic medullary thyroid cancer (MTC). Transarterial radioembolization (TARE) has been proposed to treat liver metastases (LM), especially in neuroendocrine tumors. The aim of this study… read more here.
Keywords: liver; thyroid cancer; transarterial radioembolization; medullary thyroid ... See more keywords
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib.
Sign Up to like & getrecommendations! Published in 2018 at "Future oncology"
DOI: 10.2217/fon-2017-0566
Abstract: AIM The aim was to evaluate cost-effectiveness of yttrium-90 transarterial radioembolization (TARE) in comparison to sorafenib treatment. PATIENTS & METHODS A single-center, retrospective, observational study was performed, 166Â patients with intermediate-/advanced-stage hepatocellular carcinoma were treated with… read more here.
Keywords: hepatocellular carcinoma; yttrium transarterial; tare; treatment ... See more keywords